A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders

Medical Hypotheses

Volumn 82, Issue 3, 2014, Pages 368-373

  Kountouras, Jannis ^a   Deretzi, Georgia ^a   Gavalas, Emmanouel ^a   Zavos, Christos ^a   Polyzos, Stergios A ^a   Kazakos, Evangelos ^a   Giartza Taxidou, Evangelia ^a   Vardaka, Elisabeth ^a   Kountouras, Constantinos ^a   Katsinelos, Panagiotis ^a   Boziki, Marina ^a   Giouleme, Olga ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSINS; HELICOBACTER PYLORI; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84893934189     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.12.025     Document Type: Article

References (69)

1. Wilmes M., Sahl H.G. Defensin-based anti-infective strategies. Int J Med Microbiol 2013, pii: S1438-4221(13)00131-8, [Epub ahead of print]. 10.1016/j.ijmm.2013.08.007.
2. Kolar S.S., Baidouri H., Hanlon S., McDermott A.M. Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis. Infect Immun 2013, 81:2669-2677.
3. Ho S., Pothoulakis C., Koon H.W. Antimicrobial peptides and colitis. Curr Pharm Des 2013, 19:40-47.
4. Gwyer Findlay E., Currie S.M., Davidson D.J. Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs 2013, 27:479-493.
5. Lehrer R.I. Immunology: peptide gets in shape for self-defence. Nature 2011, 469:309-310.
6. Gursoy U.K., Könönen E. Understanding the roles of gingival beta-defensins. J Oral Microbiol 2012, 4. [Article No. 15127].
7. Gupta P., Lackman-Smith C., Snyder B., et al. Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1. AIDS 2013, 29:391-396.
8. Antoni L., Nuding S., Weller D., et al. Human colonic mucus is a reservoir for antimicrobial peptides. J Crohns Colitis 2013, 7:e652-e664.
9. Niyonsaba F., Madera L., Afacan N., Okumura K., Ogawa H., Hancock R.E. The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions. J Leukoc Biol 2013, 94:159-170.
10. Ferris L.K., Mburu Y.K., Mathers A.R., et al. Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: an antimicrobial peptide that functions as an endogenous adjuvant. J Invest Dermatol 2013, 133:460-468.
11. Muniz L.R., Knosp C., Yeretssian G. Intestinal antimicrobial peptides during homeostasis, infection, and disease. Front Immunol 2012, 3:310.
12. 2+-independent apoptosis. J Innate Immun 2013, 5:290-300.
13. Hao H.-N., Zhao J., Lotoczky G., Grever W.E., Lyman W.D. Induction of human β-defensin-2 expression in human astrocytes by lipopolysaccharide and cytokines. J Neurochem 2001, 77:1027-1035.
14. Williams W.M., Castellani R.J., Weinberg A., Perry G., Smith M.A. Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration?. ScientificWorldJournal 2012, 2012:905785.
15. Zhang S., Huang N., Zhao X., et al. Construction and identification of HBD-2 transgenic mice. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2006, 23:396-399. [Article in Chinese].
16. Williams W.M., Torres S., Siedlak S.L., et al. Antimicrobial peptide beta-defensin-1 expression is upregulated in Alzheimer's brain. J Neuroinflamm 2013, 10:127.
17. Tiszlavicz Z., Endrész V., Németh B., et al. Inducible expression of human β-defensin 2 by Chlamydophila pneumoniae in brain capillary endothelial cells. Innate Immun 2011, 17:463-469.
18. Kountouras J., Gavalas E., Zavos C., et al. Alzheimer's disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med Hypotheses 2007, 68:378-388.
19. Deretzi G., Kountouras J., Grigoriadis N., et al. From the "little brain" gastrointestinal infection to the "big brain" neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis. Med Hypotheses 2009, 73:781-787.
20. Brandenburg L.-O., Varoga D., Nicolaeva N., et al. Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis. J Neuropathol Exp Neurol 2008, 67:1041-1054.
21. Phulwani N.K., Kielian T. Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation. J Neurochem 2008, 106:578-590.
22. Iribarren P., Cui Y.-H., Le Y., Wang J.M. The role of dendritic cells in neurodegenerative diseases. Arch Immunol Ther Exp 2002, 50:187-196.
23. Ciaramella A., Bizzoni F., Salani F., et al. Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease. J Alzheimers Dis 2010, 19:559-572.
24. Nuyts A.H., Lee W.P., Bashir-Dar R., Berneman Z.N., Cools N. Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?. Mult Scler 2013, 19:995-1002.
25. Fischer H.-G., Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001, 166:2717-2726.
26. Pashenkov M., Teleshova N., Link H. Inflammation in the central nervous system: the role for dendritic cells. Brain Pathol 2003, 13:23-33.
27. Maccioni R.B., Rojo L.E., Fernández J.A., Kuljis R.O. The role of neuroimmunomodulation in Alzheimer's disease. Ann N Y Acad Sci 2009, 1153:240-246.
28. Hernández-Pedro N.Y., Espinosa-Ramirez G., de la Cruz V.P., Pineda B., Sotelo J. Initial immunopathogenesis of multiple sclerosis: innate immune response. Clin Dev Immunol 2013, 2013:413465.
29. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
30. Nuding S., Gersemann M., Hosaka Y., et al. Gastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistance. PLoS One 2013, 8:e73867.
31. Lee S.K., Josenhans C. Helicobacter pylori and the innate immune system. Int J Med Microbiol 2005, 295:325-334.
32. Soylu O.B., Ozturk Y., Ozer E. Alpha-defensin expression in the gastric tissue of children with Helicobacter pylori-associated chronic gastritis: an immunohistochemical study. J Pediatr Gastroenterol Nutr 2008, 46:474-477.
33. Isomoto H., Mukae H., Ishimoto H., et al. Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection. Am J Gastroenterol 2004, 99:1916-1923.
34. Bauer B., Wex T., Kuester D., Meyer T., Malfertheiner P. Differential expression of human beta defensin 2 and 3 in gastric mucosa of Helicobacter pylori-infected individuals. Helicobacter 2013, 18:6-12.
35. Kawauchi K., Yagihashi A., Tsuji N., et al. Human beta-defensin-3 induction in H. pylori-infected gastric mucosal tissues. World J Gastroenterol 2006, 12:5793-5797.
36. Islam D., Bandholtz L., Nilsson J., et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001, 7:180-185.
37. Kountouras J., Tsolaki M., Boziki M., et al. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol 2007, 14:976-982.
38. Kountouras J., Tsolaki M., Gavalas E., et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006, 66:938-940.
39. Kountouras J., Boziki M., Gavalas E., et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci 2009, 119:765-777.
40. Kountouras J., Boziki M., Gavalas E., et al. Five-year survival following Helicobacter pylori eradication in Alzheimer's disease patients. Cogn Behav Neurol 2010, 23:199-204.
41. Roubaud-Baudron C., Krolak-Salmon P., Quadrio I., Mégraud F., Salles N. Impact of chronic Helicobacter pylori infection on Alzheimer's disease preliminary results. Neurobiol Aging 2012, 33:1009. e11-9.
42. Beydoun M.A., Beydoun H.A., Shroff M.R., Kitner-Triolo M.H., Zonderman A.B. Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosom Med 2013, 75:486-496.
43. Katan M., Moon Y.P., Paik M.C., Sacco R.L., Wright C.B., Elkind M.S. Infectious burden and cognitive function: the Northern Manhattan study. Neurology 2013, 80:1209-1215.
44. Suttkus A., Rohn S., Jäger C., Arendt T., Morawski M. Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. Am J Neurodegener Dis 2012, 1:122-129.
45. Gavalas E., Kountouras J., Deretzi G., et al. Helicobacter pylori and multiple sclerosis. J Neuroimmunol 2007, 188:187-189.
46. Deretzi G., Kountouras J., Gavalas E., et al. Multiple sclerosis and seizures: possible role of Helicobacter pylori. Eur J Neurol 2011, 18:e116.
47. Kountouras J., Mylopoulos N., Boura P., et al. Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology 2001, 108:599-604.
48. Kountouras J., Mylopoulos N., Chatzopoulos D., et al. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma. Arch Intern Med 2002, 162:1237-1244.
49. Kountouras J., Mylopoulos N., Konstas A.G., Zavos C., Chatzopoulos D., Boukla A. Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 2003, 241:884-890.
50. Kountouras J. Helicobacter pylori: an intruder involved in conspiring glaucomatous neuropathy. Br J Ophthalmol 2009, 93:1413-1415.
51. Zavos C., Kountouras J., Sakkias G., Venizelos I., Deretzi G., Arapoglou S. Histological presence of Helicobacter pylori bacteria in the trabeculum and iris of patients with primary open-angle glaucoma. Ophthalmic Res 2012, 47:150-156.
52. Kountouras J., Zavos C., Deretzi G. Primary open-angle glaucoma. N Engl J Med 2009, 360:2679.
53. Kountouras J., Zavos C., Sakkias G., et al. Helicobacter pylori infection as a risk factor for both primary open-angle glaucoma and pseudoexfoliative glaucoma in Thessaloniki eye study. Am J Ophthalmol 2011, 152:1079-1080.
54. Kountouras J., Zavos C., Polyzos S.A., et al. Helicobacter pylori infection and Parkinson's disease: apoptosis as an underlying common contributor. Eur J Neurol 2012, 19:e56.
55. Kountouras J., Deretzi G., Gavalas E., et al. Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica. J Neuroimmunol 2013, 263:162-163.
56. Kountouras J., Zavos C., Deretzi G., et al. Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis. Hepatology 2013, 57:1284.
57. Erichev V.P., Gankovskaia L.V., Koval'chuk L.V., Gankovskaia O.A., Dugina A.E. Changes in various immunological parameters of lacrimal fluid in excessive scarring after antiglaucoma surgery in patients with primary open-angle glaucoma. Vestn Oftalmol 2010, 126:25-29.
58. Paulsen F.P., Pufe T., Schaudig U., et al. Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci 2001, 42:2157-2163.
59. Kountouras J., Zavos C., Polyzos S.A., et al. Is Helicobacter pylori the usual suspect behind gastroesophageal reflux disease and dacryostenosis?. Med Hypotheses 2013, 81:147.
60. Alvarez-Arellano L., Camorlinga-Ponce M., Maldonado-Bernal C., Torres J. Activation of human neutrophils with Helicobacter pylori and the role of Toll-like receptors 2 and 4 in the response. FEMS Immunol Med Microbiol 2007, 51:473-479.
61. Kocsis A.K., Ocsovszky I., Tiszlavicz L., Tiszlavicz Z., Mándi Y. Helicobacter pylori induces the release of alpha-defensin by human granulocytes. Inflamm Res 2009, 58:241-247.
62. Schluesener H., Meyermann R. Neutrophilic defensins penetrate the blood-brain barrier. J Neurosci Res 1995, 42:718-723.
63. Itzhaki R.F., Wozniak M.A., Appelt D.M., et al. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 2004, 25:619-620.
64. Deen N.S., Huang S.J., Gong L., Kwok T., Devenish R.J. The impact of autophagic processes on the intracellular fate of Helicobacter pylori: more tricks from an enigmatic pathogen?. Autophagy 2013, 9:639-652.
65. Greenfield L.K., Jones N.L. Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol 2013, 21:602-612.
66. Zu Y., Cassai N.D., Sidhu G.S. Light microscopic and ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori by neutrophils. Ultrastruct Pathol 2000, 24:319-323.
67. Andersen L.P., Blom J., Nielsen H. Survival and ultrastructural changes of Helicobacter pylori after phagocytosis by human polymorphonuclear leukocytes and monocytes. APMIS 1993, 101:61-72.
68. Hocès de la Guardia A., Staedel C., Kaafarany I., et al. Inflammatory cytokine and microRNA responses of primary human dendritic cells cultured with Helicobacter pylori strains. Front Microbiol 2013, 4:236.
69. Deretzi G., Kountouras J., Polyzos S.A., et al. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med 2011, 11:696-707.